15 | Case study of identified adverse drug reaction associated gene with personal genome sequence | TopicSem |
05 | Discussion about case study result of ADR related gene detection | SysBiol | ||
09 | Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations | J.Club |
13 | Review and cleansing of DITOP database | SysBiol | ||
30 | Identification of adverse drug reaction associated gene with personal genome sequence for deciphering personal ADR outbreak | Seminar |
10 | Research for find out mechanism of ADR outbreak | TopicSem | ||
11 | Find module related to ADR class in 1000Genome individual | SysBiol |
04 | Apply CCLE data to personal pharmacogenomics research | SysBiol | ||
05 | Research scheme for find out mechanism of ADR outbreak | TopicSem | ||
18 | Research to find out ADR mechanism | SysBiol |
12 | Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data | J.Club | ||
21 | Drug database for personal genome interpretation | TopicSem |
03 | Review and statistics of PharmGKB | SysBiol | ||
23 | Circularity problem in PharmRank validation | TopicSem |
19 | PharmRank case study - Warfarin | TopicSem | ||
24 | Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations | J.Club |
15 | Medappllo : Drug ranking forecast algorithm based on personal genomic variation | TopicSem | ||
30 | Review of eQTL analysis | SysBiol |
05 | MedCassandra : Drug and ADR ranking forecast system based on personal genomic variation | Seminar |
18 | Adjustment of drug and ADR ranking using 1000genome | xMutant | ||
20 | Summary of MedCassandra | MAInfo | ||
24 | Adjustment of ranking algorithm and Validation of ranking result | TopicSem |
11 | process of drug & ADR ranking calculation | MAInfo | ||
25 | Drug database integration for cancer drug research | MAInfo | ||
31 | 1st result of drug and ADR rankin MedCassandra | TopicSem |
01 | Review of PharmGKB data open policy | SysBiol | ||
27 | Drug Information Retrieval System (DIR) | TopicSem |
02 | Finding repositioning drug candidate among structure-based drug network | TopicSem | ||
07 | comparing drug network based on chemical structure vs. gene expression profile simiarlity | xMutant | ||
14 | summary of chemical structure baseddrug repositioning & plan for expression profile based study | TopicSem | ||
25 | Prioritization of adverse drug reaction susceptibility based on personal genomic variants | Seminar |
19 | Using chemical structure similarity for drug repositioning | TopicSem | ||
24 | Systematic Drug Repositioning Based on Clinical Side-Effects | J.Club |
18 | [completion of replication] Discovery of drug mode of action and drug repositioning from transcriptional responses | TopicSem | ||
19 | summary of paper replication work and discuss next step | xMutant |
08 | input of drug use monitoring agent | BioEMR | ||
15 | input of drug use monitoring agent development | BioEMR | ||
22 | Pharmacology network for drug repositioning | xMutant |
02 | Pharmacology network for drug repositioning | xMutant | ||
05 | drug use monitoring agent plan | BioEMR | ||
14 | Pharmacology network for drug repositioning | xMutant | ||
26 | Agent | BioEMR |
24 | Health Avatar ó ( ü ) | BioEMR |
19 | [mini-j] Adverse drug reactions - definitions, diagnosis, and management | BioEMR |